A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
352 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Alexander Fleming
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Idim - Instituto de Investigaciones Metabólicas
Ciudad de Buenos Aires, Buenos Aires, Argentina
Recruiting - Hospital Universitario Austral
Pilar, Buenos Aires, Argentina
Recruiting - Hospital Italiano de Buenos Aires
ABB, Buenos Aires F.D., Argentina
Recruiting - Local Institution - 0571
Buenos Aires, Buenos Aires F.D., Argentina
Withdrawn - Clinica Adventista Belgrano
CABA, Buenos Aires F.D., Argentina
Recruiting - Sanatorio Plaza
Rosario, Santa Fe Province, Argentina
Recruiting
- Canberra Hospital
Canberra, Australian Capital Territory, Australia
Recruiting - Tamworth Hospital
North Tamworth, New South Wales, Australia
Recruiting - Orange Hospital
Orange, New South Wales, Australia
Recruiting - Princess Alexandra Hospital
Brisbane, Queensland, Australia
Recruiting - Lyell Mcewin Hospital
Elizabeth Vale, South Australia, Australia
Recruiting - Frankston Hospital
Frankston, Victoria, Australia
Recruiting - Northern Hospital
Melbourne, Victoria, Australia
Recruiting - Latrobe Regional Health
Traralgon, Victoria, Australia
Recruiting - Joondalup Health Campus
Joondalup, Western Australia, Australia
Recruiting
- Medizinische Universität Graz
Graz, Styria, Austria
Recruiting - Klinikum Wels-Grieskirchen Gmbh
Wels, Upper Austria, Austria
Recruiting - Kepler Universitätsklinikum
Linz, Austria
Recruiting - Klinik Floridsdorf
Vienna, Austria
Recruiting - Medizinische Universität Wien
Vienna, Austria
Recruiting
- Cliniques Universitaires Saint-Luc
Brussels, Bruxelles-Capitale, Région de, Belgium
Recruiting - Uz Brussel
Brussels, Bruxelles-Capitale, Région de, Belgium
Recruiting - Jessa Ziekenhuis
Hasselt, Limburg, Belgium
Recruiting - Az Maria Middelares
Ghent, Oost-Vlaanderen, Belgium
Recruiting - Uz Leuven
Leuven, Vlaams-Brabant, Belgium
Recruiting - Centre Hospitalier Universitaire de Liège - Domaine Universitaire Du Sart Tilman
Liège, Belgium
Recruiting
- Cedoes
Vitória, Espírito Santo, Brazil
Recruiting - Nucleo de Oncologia Da Bahia
Salvador, Estado de Bahia, Brazil
Recruiting - Cetus Oncologia - Unidade Belo Horizonte
Belo Horizonte, Minas Gerais, Brazil
Recruiting - Oncosite - Centro de Pesquisa Clinica Em Oncologia
Ijuí, Rio Grande do Sul, Brazil
Recruiting - Hospital São Lucas Da Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Instituto de Oncologia Saint Gallen
Santa Cruz do Sul, Rio Grande do Sul, Brazil
Recruiting - Hospital de Amor Amazônia
Porto Velho, Rondônia, Brazil
Recruiting - Clínica de Oncologia Reichow
Blumenau, Santa Catarina, Brazil
Recruiting - Clínica de Neoplasias Litoral
Itajaí, Santa Catarina, Brazil
Recruiting - Fundação Pio Xii - Hospital de Câncer de Barretos
Barretos, São Paulo, Brazil
Recruiting - Advanze Pesquisa
São Carlos, São Paulo, Brazil
Recruiting - Fundação Faculdade Regional de Medicina de São José Do Rio Preto
São José do Rio Preto, São Paulo, Brazil
Recruiting - A. C. Camargo Cancer Center
São Paulo, São Paulo, Brazil
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Apr 2025
- Primary completion
- 7 Sept 2029
- Completion
- 30 Apr 2032
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 630
- Registry id
- NCT06875310
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.